These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 22829722)

  • 21. Universal Dengue Vaccine Elicits Neutralizing Antibodies against Strains from All Four Dengue Virus Serotypes.
    Uno N; Ross TM
    J Virol; 2021 Jan; 95(4):. PubMed ID: 33208445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural landscape of the complete genomes of dengue virus serotypes and other viral hemorrhagic fevers.
    Delli Ponti R; Mutwil M
    BMC Genomics; 2021 May; 22(1):352. PubMed ID: 34000991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conservation and variability of dengue virus proteins: implications for vaccine design.
    Khan AM; Miotto O; Nascimento EJ; Srinivasan KN; Heiny AT; Zhang GL; Marques ET; Tan TW; Brusic V; Salmon J; August JT
    PLoS Negl Trop Dis; 2008 Aug; 2(8):e272. PubMed ID: 18698358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting of highly conserved Dengue virus sequences with anti-Dengue virus trans-splicing group I introns.
    Carter JR; Keith JH; Barde PV; Fraser TS; Fraser MJ
    BMC Mol Biol; 2010 Nov; 11():84. PubMed ID: 21078188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adenovirus type 5 vectors encoding short hairpin RNAs targeting dengue virus 5' non-translated region and capsid gene suppress pre-established dengue infection in cultured epithelial and myeloid cells.
    Beesetti H; Swaminathan S
    Virus Res; 2021 Oct; 304():198527. PubMed ID: 34339773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of Dengue Virus NS4B Inhibitors.
    Wang QY; Dong H; Zou B; Karuna R; Wan KF; Zou J; Susila A; Yip A; Shan C; Yeo KL; Xu H; Ding M; Chan WL; Gu F; Seah PG; Liu W; Lakshminarayana SB; Kang C; Lescar J; Blasco F; Smith PW; Shi PY
    J Virol; 2015 Aug; 89(16):8233-44. PubMed ID: 26018165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of a dengue NS4B inhibitor originating from an HCV small molecule library.
    Hernandez-Morales I; Geluykens P; Clynhens M; Strijbos R; Goethals O; Megens S; Verheyen N; Last S; McGowan D; Coesemans E; De Boeck B; Stoops B; Devogelaere B; Pauwels F; Vandyck K; Berke JM; Raboisson P; Simmen K; Lory P; Van Loock M
    Antiviral Res; 2017 Nov; 147():149-158. PubMed ID: 29037976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nuclear localization of dengue virus (DENV) 1-4 non-structural protein 5; protection against all 4 DENV serotypes by the inhibitor Ivermectin.
    Tay MY; Fraser JE; Chan WK; Moreland NJ; Rathore AP; Wang C; Vasudevan SG; Jans DA
    Antiviral Res; 2013 Sep; 99(3):301-6. PubMed ID: 23769930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Modified mRNA Vaccine Targeting Immunodominant NS Epitopes Protects Against Dengue Virus Infection in HLA Class I Transgenic Mice.
    Roth C; Cantaert T; Colas C; Prot M; Casadémont I; Levillayer L; Thalmensi J; Langlade-Demoyen P; Gerke C; Bahl K; Ciaramella G; Simon-Loriere E; Sakuntabhai A
    Front Immunol; 2019; 10():1424. PubMed ID: 31293584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of novel antiviral peptides against dengue serotypes 1-4.
    Lee MF; Anasir MI; Poh CL
    Virology; 2023 Mar; 580():10-27. PubMed ID: 36739680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dengue Virus NS Proteins Inhibit RIG-I/MAVS Signaling by Blocking TBK1/IRF3 Phosphorylation: Dengue Virus Serotype 1 NS4A Is a Unique Interferon-Regulating Virulence Determinant.
    Dalrymple NA; Cimica V; Mackow ER
    mBio; 2015 May; 6(3):e00553-15. PubMed ID: 25968648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of an Arylnaphthalene Lignan Derivative as an Inhibitor against Dengue Virus Serotypes 1 to 4 (DENV-1 to -4) Using a Newly Developed DENV-3 Infectious Clone and Replicon.
    Hu M; Li WF; Wu T; Yang Y; Chen G; Chen T; Liu Y; Mei Y; Wu D; Wei Y; Luo T; Zhang HJ; Li YP
    Microbiol Spectr; 2023 Aug; 11(4):e0042323. PubMed ID: 37378517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serotype-specific interactions among functional domains of dengue virus 2 nonstructural proteins (NS) 5 and NS3 are crucial for viral RNA replication.
    Teramoto T; Balasubramanian A; Choi KH; Padmanabhan R
    J Biol Chem; 2017 Jun; 292(23):9465-9479. PubMed ID: 28396347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chikungunya nsP4 homology modeling reveals a common motif with Zika and Dengue RNA polymerases as a potential therapeutic target.
    Reyes-Gastellou A; Jiménez-Alberto A; Castelán-Vega JA; Aparicio-Ozores G; Ribas-Aparicio RM
    J Mol Model; 2021 Aug; 27(9):247. PubMed ID: 34386905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two RNA Tunnel Inhibitors Bind in Highly Conserved Sites in Dengue Virus NS5 Polymerase: Structural and Functional Studies.
    Arora R; Liew CW; Soh TS; Otoo DA; Seh CC; Yue K; Nilar S; Wang G; Yokokawa F; Noble CG; Chen YL; Shi PY; Lescar J; Smith TM; Benson TE; Lim SP
    J Virol; 2020 Nov; 94(24):. PubMed ID: 32907977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Complete Genome Phylogeny of Geographically Distinct Dengue Virus Serotype 2 Isolates (1944-2013) Supports Further Groupings within the Cosmopolitan Genotype.
    Ali A; Ali I
    PLoS One; 2015; 10(9):e0138900. PubMed ID: 26414178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of dengue virus by targeting viral NS4B protein.
    Xie X; Wang QY; Xu HY; Qing M; Kramer L; Yuan Z; Shi PY
    J Virol; 2011 Nov; 85(21):11183-95. PubMed ID: 21865382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Full-length genome and molecular characterization of dengue virus serotype 2 isolated from an imported patient from Myanmar.
    Zeng Z; Shi J; Guo X; Mo L; Hu N; Sun J; Wu M; Zhou H; Hu Y
    Virol J; 2018 Aug; 15(1):131. PubMed ID: 30126417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delivery of antiviral small interfering RNA with gold nanoparticles inhibits dengue virus infection in vitro.
    Paul AM; Shi Y; Acharya D; Douglas JR; Cooley A; Anderson JF; Huang F; Bai F
    J Gen Virol; 2014 Aug; 95(Pt 8):1712-1722. PubMed ID: 24828333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design and production of dengue virus chimeric proteins useful for developing tetravalent vaccines.
    Batista ICA; Quinan BR; Rocha Alves ÉA; Jangola STG; Oliveira ES; Colombarolli SG; Ferreira JGG; Rocha ESO; Kroon EG; de Assis RR; de Oliveira JG; Fiuza JA; Calzavara-Silva CE
    Vaccine; 2020 Feb; 38(8):2005-2015. PubMed ID: 31982262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.